Annual SG&A
$5.73 M
+$80.00 K+1.42%
31 December 2023
Summary:
RenovoRx annual selling, general & administrative expenses is currently $5.73 million, with the most recent change of +$80.00 thousand (+1.42%) on 31 December 2023. During the last 3 years, it has risen by +$4.91 million (+600.37%). RNXT annual SG&A is now at all-time high.RNXT Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.18 M
-$314.00 K-21.05%
30 September 2024
Summary:
RenovoRx quarterly selling, general & administrative expenses is currently $1.18 million, with the most recent change of -$314.00 thousand (-21.05%) on 30 September 2024. Over the past year, it has dropped by -$176.00 thousand (-13.00%). RNXT quarterly SG&A is now -38.74% below its all-time high of $1.92 million, reached on 31 March 2023.RNXT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$176.10 M
-$9.16 M-5.49%
30 September 2024
Summary:
RenovoRx TTM selling, general & administrative expenses is currently -$176.10 million, with the most recent change of -$9.16 million (-5.49%) on 30 September 2024. Over the past year, it has dropped by -$182.22 million (-2976.93%). RNXT TTM SG&A is now -1077.12% below its all-time high of $6.12 million, reached on 30 September 2023.RNXT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNXT Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.4% | -13.0% | -2976.9% |
| 3 y3 years | +600.4% | +87.6% | -10000.0% |
| 5 y5 years | - | - | - |
RNXT Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +600.4% | -38.7% | +87.6% | -161.2% | at low |
| 5 y | 5 years | at high | +600.4% | -38.7% | +543.7% | -1077.1% | at low |
| alltime | all time | at high | +600.4% | -38.7% | +543.7% | -1077.1% | at low |
RenovoRx Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.18 M(-21.0%) | $4.89 M(-3.5%) |
| June 2024 | - | $1.49 M(+22.4%) | $5.07 M(+0.8%) |
| Mar 2024 | - | $1.22 M(+21.7%) | $5.03 M(-12.3%) |
| Dec 2023 | $5.73 M(+1.4%) | $1.00 M(-26.0%) | $5.73 M(-6.4%) |
| Sept 2023 | - | $1.35 M(-6.6%) | $6.12 M(+0.6%) |
| June 2023 | - | $1.45 M(-24.6%) | $6.08 M(+3.9%) |
| Mar 2023 | - | $1.92 M(+37.9%) | $5.86 M(+3.7%) |
| Dec 2022 | $5.65 M | $1.39 M(+6.0%) | $5.65 M(+2.5%) |
| Sept 2022 | - | $1.31 M(+7.4%) | $5.51 M(+14.2%) |
| June 2022 | - | $1.22 M(-28.7%) | $4.82 M(+22.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.72 M(+36.7%) | $3.93 M(+49.3%) |
| Dec 2021 | $2.63 M(+221.8%) | $1.25 M(+99.8%) | $2.63 M(+68.3%) |
| Sept 2021 | - | $628.00 K(+90.3%) | $1.56 M(+39.8%) |
| June 2021 | - | $330.00 K(-21.1%) | $1.12 M(+13.2%) |
| Mar 2021 | - | $418.00 K(+123.5%) | $988.00 K(+20.8%) |
| Dec 2020 | $818.00 K(-9.0%) | - | - |
| Dec 2020 | - | $187.00 K(+2.2%) | $818.00 K(+29.6%) |
| Sept 2020 | - | $183.00 K(-8.5%) | $631.00 K(+40.8%) |
| June 2020 | - | $200.00 K(-19.4%) | $448.00 K(+80.6%) |
| Mar 2020 | - | $248.00 K | $248.00 K |
| Dec 2019 | $899.00 K | - | - |
FAQ
- What is RenovoRx annual selling, general & administrative expenses?
- What is the all time high annual SG&A for RenovoRx?
- What is RenovoRx annual SG&A year-on-year change?
- What is RenovoRx quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for RenovoRx?
- What is RenovoRx quarterly SG&A year-on-year change?
- What is RenovoRx TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for RenovoRx?
- What is RenovoRx TTM SG&A year-on-year change?
What is RenovoRx annual selling, general & administrative expenses?
The current annual SG&A of RNXT is $5.73 M
What is the all time high annual SG&A for RenovoRx?
RenovoRx all-time high annual selling, general & administrative expenses is $5.73 M
What is RenovoRx annual SG&A year-on-year change?
Over the past year, RNXT annual selling, general & administrative expenses has changed by +$80.00 K (+1.42%)
What is RenovoRx quarterly selling, general & administrative expenses?
The current quarterly SG&A of RNXT is $1.18 M
What is the all time high quarterly SG&A for RenovoRx?
RenovoRx all-time high quarterly selling, general & administrative expenses is $1.92 M
What is RenovoRx quarterly SG&A year-on-year change?
Over the past year, RNXT quarterly selling, general & administrative expenses has changed by -$176.00 K (-13.00%)
What is RenovoRx TTM selling, general & administrative expenses?
The current TTM SG&A of RNXT is -$176.10 M
What is the all time high TTM SG&A for RenovoRx?
RenovoRx all-time high TTM selling, general & administrative expenses is $6.12 M
What is RenovoRx TTM SG&A year-on-year change?
Over the past year, RNXT TTM selling, general & administrative expenses has changed by -$182.22 M (-2976.93%)